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Salmonella enterica is a major cause of morbidity worldwide and mortality in children and immunocompro-
mised individuals in sub-Saharan Africa. Outer membrane proteins of Salmonella are of significance because
they are at the interface between the pathogen and the host, they can contribute to adherence, colonization, and
virulence, and they are frequently targets of antibody-mediated immunity. In this study, the properties of SadA,
a purported trimeric autotransporter adhesin of Salmonella enterica serovar Typhimurium, were examined. We
demonstrated that SadA is exposed on the Salmonella cell surface in vitro and in vivo during infection of mice.
Expression of SadA resulted in cell aggregation, biofilm formation, and increased adhesion to human intestinal
Caco-2 epithelial cells. Immunization of mice with folded, full-length, purified SadA elicited an IgG response
which provided limited protection against bacterial challenge. When anti-SadA IgG titers were enhanced by
administering alum-precipitated protein, a modest additional protection was afforded. Therefore, despite SadA
having pleiotropic functions, it is not a dominant, protective antigen for antibody-mediated protection against
Salmonella.
Nontyphoidal strains of Salmonella (NTS) such as Salmo-
nella enterica serovar Typhimurium are a major cause of hu-
man gastrointestinal infections and invasive disease. While
NTS cause almost 100 million cases of gastroenteritis globally
every year (54), invasive disease is a huge, yet underrecognized
problem in regions such as sub-Saharan Africa, where it typi-
cally manifests as bacteremia and meningitis in young children
(30) and HIV-infected individuals (28). Invasive disease is as-
sociated with high case-fatality rates and often occurs in the
complete absence of gastrointestinal symptoms. Evidence
points to a lack of specific antibody as a main contributing
factor to severe infection and bacteremia (27, 53), making
vaccine development a promising preventive option. Further-
more, antibiotic resistance in these bacteria is an increasing
problem (29), and development of new intervention and pre-
ventative strategies is urgently required. Outer membrane pro-
teins are part of the interface between pathogen and host, are
targets of antibody, and are therefore potential candidates for
vaccine development (14, 52). An improved knowledge of the
surface-expressed virulence factors of S. Typhimurium is es-
sential to understand bacterial virulence and to identify novel
vaccine targets on the bacterium.
The S. Typhimurium protein SadA belongs to the family of
trimeric autotransporter adhesins (TAAs), a subset of type V
secreted proteins that form a stable trimer on the bacterial cell
surface (12, 32, 38). TAAs, like all type V secreted proteins,
contain an N-terminal sec-dependent signal sequence that al-
lows the protein to cross the inner membrane, an internal
passenger domain, and a C-terminal translocation domain (18,
34, 36, 37). TAAs are distinguished from conventional auto-
transporters (ATs) by having a small 70- to 100-amino-acid
(aa) translocation domain, composed of four -strands, which
forms a homotrimer resulting in a full-sized -barrel pore in
the outer membrane (71). This pore is essential for transport of
the passenger domain to the cell surface (61, 71). The -barrel
is inserted into the outer membrane via the -barrel assembly
machinery (BAM) complex, and thereafter, the passenger do-
main is secreted to the cell surface (44, 48).
The passenger domains of TAAs share common features.
Structural determinations of TAA proteins such as YadA, Hia,
and BadA have revealed three distinct regions within the pas-
senger domain: an N-terminal head, a neck, and a stalk (56, 72,
* Corresponding author. Mailing address: School of Immunity and
Infection, University of Birmingham, Edgbaston, Birmingham B15
2TT, United Kingdom. Phone: 44 121 4144368. Fax: 121 4143599.
E-mail: i.r.henderson@bham.ac.uk.
‡ These authors contributed equally to the research.
§ Present address: Department of Veterinary Medicine, University
of Cambridge, Cambridge, United Kingdom.
† Supplemental material for this article may be found at http://iai
.asm.org/.
 Published ahead of print on 22 August 2011.
4342
 o
n
 O
ctober 26, 2016 by University of Queensland Library
http://iai.asm
.org/
D
ow
nloaded from
 
81). The stalk is an -helical region which spans the pore
formed by the translocation unit in a manner analogous to the
classical ATs. The neck region connects the stalk to the head
domain. The YadA head structure contains single-stranded,
left-handed helices, with the interface between them being
formed by periodically occurring, conserved sequence motifs
(56). These motifs can be found in the predicted head struc-
tures of many TAAs, and variations in this region are largely
responsible for the functional variation observed for these pro-
teins (56, 81).
Where characterized, TAAs are uniformly associated with
adhesion (50), but they may also have other virulence proper-
ties. The exemplar TAA is YadA from Yersinia enterocolitica,
which mediates adhesion to epithelial cells and extracellular
matrix (ECM) molecules and is also crucial for intestinal col-
onization and serum resistance (3, 22, 73). Other characterized
trimeric autotransporters include NadA and NhhA from Neis-
seria meningitidis, which facilitate binding and invasion of ep-
ithelial cells (11, 62); BadA from Bartonella henselae, which
plays a role in binding to ECM proteins (40, 60); Hia and Hsf
from Haemophilus influenzae, which enable high-affinity bind-
ing to respiratory epithelial cells (13, 46); and UspA1 and
UspA2 from Moraxella catarrhalis, which mediate binding to
human epithelial cells (47). Recently, a trimeric autotrans-
porter from uropathogenic Escherichia coli, UpaG, which is
required for binding to bladder epithelial cells and the ECM
proteins fibronectin and laminin, has been described (10, 75).
It also promotes autoaggregation and biofilm formation (75).
SadA has not been established as playing a role in S. Typhi-
murium infection. We investigated the cellular localization of
SadA, its functions, and the role that antibody to SadA may
play in controlling S. Typhimurium infection.
MATERIALS AND METHODS
Cells and culture conditions. The bacterial strains and plasmids used in this
study are listed in Table 1. All bacterial strains were routinely cultured in
Luria-Bertani (LB) broth or M63 minimal medium (58) with shaking or on agar
at 37°C supplemented with kanamycin (50 g/ml), ampicillin (100 g/ml), and/or
1 mM isopropyl--D-thiogalactopyranoside (IPTG) where appropriate. The
semiadherent macrophage-like cell line J774 and the colorectal carcinoma cell
line Caco-2 were cultured in Dulbecco’s modified Eagle’s medium (DMEM), as
previously described (51, 69).
Molecular biology techniques and strain construction. Plasmid DNA isola-
tion, genomic DNA isolation, PCR product purification, and agarose gel extrac-
tions were performed with the relevant kits from Qiagen according to the man-
ufacturer’s instructions. All restriction enzymes (New England BioLabs) and T4
DNA ligases (Promega) were used in accordance with the manufacturer’s spec-
ifications. PCR experiments were performed using Phusion high-fidelity DNA
polymerase (F530-L; New England BioLabs) or 1 ReddyMix PCR master mix
(Ab-0575; Thermo Scientific). DNA sequencing was carried out at the Func-
tional Genomics and Proteomics Laboratory of the University of Birmingham.
To obtain RNA, either bacterial cultures were harvested in the presence of
Qiagen RNAprotect bacterial reagent or spleen sections were homogenized
using a Qiagen QIAshredder. Subsequently, RNA was isolated using Qiagen’s
RNeasy minikit and RNase-Free DNase set in accordance with the manufac-
turer’s instructions. RNA was quantified using NanoDrop prior to cDNA
synthesis using SuperScript II reverse transcriptase and random hexamers (In-
vitrogen) and prior to reverse transcriptase (RT)-PCR using Taq polymerase and
primers D3 and RT1. Primers used in the study are listed in Table S1 in the
supplemental material.
The sadA gene was amplified by PCR from S. enterica SL1344 using primers
D5 and D6 (see Table S1 in the supplemental material). The PCR product
containing the full-length sadA gene was digested with NdeI and EcoRI and
ligated to the pET22b (Novagen) plasmid digested with the same enzymes to
generate pDR01. The pDR03 plasmid contained the full-length sadA gene,
amplified with primers D5 and D7 and cloned into a modified pQE60 vector
(pQE60NdeI; see Table 1 for details) between the restriction sites NdeI and
HindIII.
The sadA mutant strains were generated using the one-step gene inactivation
method described for E. coli and S. Typhimurium (16, 21). Briefly, the kanamycin
resistance cassette was amplified using primers D1 and D2, which possessed 40
bp that were identical to regions within sadA. The resulting DNA was trans-
TABLE 1. Strains and plasmids used in this study
Strain or plasmid Characteristic Referenceor source
Strains
S. enterica
SL1344 Wild-type Salmonella enterica serovar Typhimurium 80
SL1344 sadA::aph Part of sadA gene replaced with kanamycin resistance cassette This study
SL1344 sadA SL1344 sadA::aph with aph cassette resolved This study
SL3261 Attenuated Salmonella enterica serovar Typhimurium SL1344 aroA 39
SL3261 sadA::aph Part of sadA gene replaced with kanamycin resistance cassette This study
SL3261 sadA SL3261 sadA::aph with aph cassette resolved This study
SL3261 galE::aph The galE gene replaced with kanamycin resistance cassette This study
SL3261 sadA galE::aph The galE gene replaced with kanamycin resistance cassette This study
E. coli
M15(pREP4) For regulated high-level expression with pQE vectors Qiagen
HB101 Nonaggregating E. coli laboratory strain 9
BL21 E. coli DE3 protein expression strain Invitrogen
Plasmids
pET22b IPTG-inducible expression vector Invitrogen
pDR01 sadA gene in the NdeI-EcoRI sites of pET22b This study
pQE60 IPTG-inducible expression vector Qiagen
pQE60 NdeI pQE60 with added NdeI restriction site in the multiple-cloning site
and previously existing NdeI site removed
This study
pDR03 pQE60NdeI carrying sadA gene in the NdeI-HindIII site This study
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formed into S. enterica SL1344 carrying the pKD46 plasmid encoding the  red
recombinase. Disruption of sadA was confirmed by PCR using primers k1, k2,
and kt (16) in combination with primers D3 (upstream check primer) and D4
(downstream check primer) and subsequent DNA sequencing. The mutation was
then P22 transduced into S. enterica SL1344 and S. enterica SL3261, generating
the strains S. enterica SL1344 sadA::aph and SL3261 sadA::aph, respectively.
These latter strains were used to create S. enterica SL1344 sadA and SL3261
sadA by removing the kanamycin cassette as previously described (16).
Protein localization and Western blotting. Cellular fractions were prepared as
described previously (59). Cellular fractions and purified proteins were electro-
phoresed on 10% SDS-PAGE gels and stained with Coomassie blue or trans-
ferred to a polyvinylidene difluoride (PVDF) membrane for Western blotting as
previously described (76). Western blotting was performed with a 1:1,000 dilu-
tion of the anti-SadA antibody and a 1:10,000 anti-rabbit dilution of IgG alkaline
phosphatase before detection with NBP-BCIP (nitroblue tetrazolium chloride–
5-bromo-4-chloro-3-indolylphosphate) (Sigma) as the substrate. Proteins were
localized by immunofluorescence as described previously (76). Briefly, 13-mm
glass coverslips coated with 1 mg/ml poly L-lysine were overlaid with LB-cultured
bacteria. Subsequently, coverslips were incubated with phosphate-buffered saline
(PBS) containing 4% formalin, followed by a PBS-bovine serum albumin (PBS-
BSA) blocking buffer. SadA was detected with anti-SadA antibody (1:100 in
PBS-BSA) and, subsequently, goat anti-rabbit (GAR) Alexa Fluor 488 secondary
antibody (1:100 in PBS-BSA) before visualization on a Leica DMRE fluores-
cence microscope-DC200 digital camera system. Captured images are represen-
tative of randomly selected fields of view.
Purification of full-length SadA protein. E. coli BL21(pDR01) was grown with
IPTG induction until an optical density at 600 nm (OD600) of 1 was reached.
Cells were pelleted by centrifugation, washed, and resuspended in 50 mM
HEPES, 150 mM sodium chloride, 1 mM phenylmethylsulfonyl fluoride (PMSF),
pH 7.4. Cells were lysed by sonication, and the cell debris and inclusion bodies
were pelleted by centrifugation at 20,000  g. The pellet was resuspended in 50
mM HEPES, 150 mM NaCl, 8 M urea, 1 mM PMSF, pH 7.4, and incubated at
room temperature for 1 h. Subsequently, insoluble material was removed by
centrifugation at 50,000  g, and the supernatant was recovered. This SadA-
containing solution was run on SDS-PAGE gels, bands corresponding to SadA
were excised, and gel slices were homogenized in 0.5 ml of 50 mM HEPES, 0.1%
SDS, pH 7.4. SadA was electroeluted in a Novagen elution system per the
manufacturer’s instructions. The eluted protein was diluted to 10 ml in 50 mM
HEPES, 0.1% SDS, pH 7.4, and then dialyzed three times against 5 liters of 50
mM HEPES, 150 mM NaCl, 0.5% Elugent detergent (Calbiochem). Refolding
by dialysis was performed over 3 days. The concentration of the protein was
estimated using a tannin assay. BSA made up in the final refolding buffer was
used as the standard. Tryptophan fluorescence readings were taken at 280-nm
excitation, with emission scanned over 300 to 450 nm, with a 0.5-mm slit width,
an 1-nm bandwidth, a 1-s response time, and 1-nm increments using a Quan-
taMaster instrument (Photon Technologies International). These purified SadA
protein preparations were tested with an endotoxin assay (Sigma E-Toxate kit) to
measure levels of lipopolysaccharide (LPS). Antibodies against SadA were raised
in New Zealand White rabbits using the purified refolded protein described
above.
Autoaggregation and biofilm assays. Autoaggregation was observed as de-
scribed previously (77). The rate of autoaggregation was determined as the mean
decrease in optical density over time. Biofilm formation on polystyrene surfaces
was studied using 96-well microtiter plates as described previously (65). All the
experiments were performed in triplicate on three separate days. Flow chamber
experiments were performed as previously described (77), with the exception
that the media also contained BacLight green bacterial stain (Invitrogen) to
visualize the biofilms. Biofilm development was monitored at 18 h and 24 h after
inoculation. All experiments were performed in triplicate.
Adherence and invasion/intracellular survival assays. Tissue culture assays
were performed as previously described (77). Briefly, overnight bacterial cultures
were washed twice in 1 PBS (Invitrogen) and resuspended in serum-free
culture medium (108 CFU/ml). Plates (24-well) were seeded with 105 J774 cells
or 106 Caco-2 cells each well. For adherence assays, the washed cells were
infected with 1 ml of bacterial cultures and incubated at 37°C in a 5% CO2
atmosphere for 2 h. Subsequently, the cells were washed several times with 1
Hanks balanced salt solution (HBSS) to remove the nonadherent bacteria prior
to disruption with 1 Dulbecco’s PBS (DPBS), 1% (vol/vol) Triton X-100 solu-
tion. Serial dilution of this solution onto LB agar plates supplemented with
suitable antibiotics was used to enumerate CFU. To estimate the number of
intracellular/invasive bacteria, the infected cells were washed several times with
HBSS and then treated with 100 g/ml gentamicin for 2 h at 37°C and 5% CO2
to kill the extracellular bacteria. The number of CFU was calculated as described
above. The results were the means for three individual experiments conducted in
triplicate on three separate days. Leaf infection and confocal fluorescence mi-
croscopy were performed as previously described (6). Briefly, supermarket salad
leaves were affixed to a 30-mm petri dish base and immersed in 4 ml of the
appropriate bacterial culture prior to incubation at 20°C for 1 h, with no agita-
tion. Nonadherent bacteria were removed by washing, and the numbers of
leaf-adherent bacteria were quantified by plating on agar plates. A two-tailed,
paired Student t test was used to assess significance, using a P of 	0.05 as a
cutoff. ECM binding assays were performed as previously described (76), with all
ECM molecules (collagen I, III, and IV, fibronectin, elastin, and laminin) pur-
chased from Sigma.
Serum bactericidal assay. The serum bactericidal assays were performed as
described previously (53). Killing of S. enterica SL1344 and SL1344 sadA and
E. coli strains expressing SadA was investigated with normal serum obtained
from healthy African and European individuals. Cultures of bacteria in the log
growth phase were prepared in 1 PBS, and 10 l of each sample was added to
90 l of freshly thawed, undiluted serum to give a final bacterial concentration of
106 CFU/ml. The mixtures were incubated at 37°C with gentle rocking (20 rpm),
and 10-l samples were withdrawn at 45, 90, and 180 min. Serial dilutions of the
samples were plated onto LB agar plates to determine the viable bacterial counts.
In vivo assessment of virulence and immune response. Caenorhabditis elegans
strain Bristol N2 was cultured using standard methods, and survival assays were
performed as described previously (1, 2). The worms were grown on nematode
growth medium (NGM) agar plates and fed with E. coli strain OP50. Larval stage
4 (L-4) C. elegans worms were picked and transferred to assay plates. The plates
were incubated at 25°C and scored daily for survival. Death was defined as a
failure to respond to mechanical stimulus. A minimum of 100 worms were used
on three independent occasions. A Kaplan-Meier estimate was used to deter-
mine the probability of C. elegans survival to the next day. Survival curves were
generated by plotting probability of survival against time and were then com-
pared using the log rank test to establish whether the difference between two
curves was statistically significant.
Mice were infected intraperitoneally (i.p.) with 5  105 CFU and sacrificed
at the described times postinfection. For oral infection, mice were given 5  106
bacteria by oral gavage and sacrificed 4 or 6 days later. After the mice were
sacrificed, their blood, spleens, and livers were harvested and the bacterial counts
in their organs were measured by homogenizing the tissues and plating them
onto LB agar as described previously (14). In some experiments, mice were
immunized via the i.p. route with 10 g purified SadA protein with or without
alum precipitation as described previously (15). After immunization, for the
prescribed times, mice were bled and subsequently challenged with 5  105
CFU S. enterica SL1344 i.p. and sacrificed 2 days later. Organs and blood were
isolated at the time of sacrifice, and numbers of bacteria were enumerated as
described above. Serum was isolated from blood by centrifugation and assessed
by enzyme-linked immunosorbent assay (ELISA) for SadA-specific IgM and
total IgG titers. MaxiSorp 96-well plates (Nunc) were coated with 5 g/ml of
purified SadA in carbonate coating buffer. After washing, plates were blocked for
1 h at 37°C with 1% BSA in PBS. Subsequently, serum samples were added in
blocking buffer and serially diluted and incubation was continued for 1 h at 37°C.
Secondary goat anti-mouse IgM or IgG conjugated to alkaline phosphatase
(Southern Biotech) was diluted in blocking buffer and added for 1 h at 37°C. A
signal was detected using the SIGMAFAST p-nitrophenyl phosphate system, and
plates were read at 405 nm. In some cases, bacteria were administered after
opsonization. Before being used for opsonization, all sera were heated to 56°C
for 20 min to inactivate complement. The heat-inactivated sera and organisms
were mixed (1:200) with gentle agitation for 30 min at room temperature, the
bacterial concentration was adjusted to the concentration used for infection
(5  105 CFU), and the bacterial suspension was administered via the i.p.
route; bacteria were cultured to ensure no loss of viability.
RESULTS
Comparative sequence analysis of SadA positional ortho-
logues. Analysis of the S. enterica SL1344 genome identified
sadA, a 4,383-bp gene that encodes a TAA protein. The
1,461-aa protein is a typical TAA, possessing all of the ex-
pected features of this family. Analysis of the amino acid se-
quence revealed a putative signal sequence possessing a con-
served N-terminal extended signal peptide region (ESPR),
which is common to many autotransporter proteins (4, 17, 19,
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49), and is predicted to be cleaved after amino acid 50. The
analysis also revealed a 1,333-aa passenger domain and a C-
terminal translocation unit indicated by the Pfam:YadA
(PF03895) domain. The translocator domain is only 78 aa,
which is consistent with other TAAs that form a homotrimer to
make a full-sized -barrel. The passenger regions of TAAs
have three conserved structural features: the head, neck, and
stalk (45, 50). The head structure is composed of multiple
Pfam:Hep_Hag (PF05658) motifs, while the neck consists of a
single Pfam:HIM (PF05662) motif. The stalk is composed of
multiple small repeats that are not conserved between TAAs
and therefore does not have a Pfam identifier (50). SadA
contains these motifs (Fig. 1), suggesting that it has an N-ter-
minal head followed by a long region of alternating neck and
FIG. 1. In silico analysis of SadA protein. (A) Schematic diagram comparing SadA and UpaG proteins. Structural domains are shown as colored
boxes, and Pfam motifs are shown as follows: signal peptide (SP), pink; head, yellow; neck, orange; stalk, black; and translocation domain, green.
(B) Unrooted phylogram of full-length SadA orthologues from 32 genomes. Genomes are color coded according to pathogenesis groups. Bootstrap
values from 1,000 replicates are shown. (C) Genomic region containing sadA in S. Typhimurium LT2 and alignment to the orthologue’s region in
E. coli CFT073 and E. coli K-12.
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stalk segments similar to other long TAAs, such as BadA from
Bartonella henselae (72).
To find orthologues of SadA, the full protein sequence was
used to probe the available sequenced bacterial genomes using
BLASTP. Sequences identified by this method were then
screened to determine if they had the same domain organiza-
tion as SadA, as well as sharing over 50% similarity. This
analysis identified orthologues of SadA in E. coli (including
Shigella sonnei), Citrobacter youngae, and S. enterica genomes.
In each case, the sadA gene was found to be in the same
genomic location adjacent to the lld locus, suggesting that sadA
was acquired prior to the divergence of these species (Fig. 1C).
A multiple alignment of the full-length proteins revealed that
the proteins from Salmonella were very well conserved, sharing
over 98% similarity with each other, whereas the proteins from
E. coli were more variable (Fig. 1B). A phylogenetic tree was
created from the multiple alignments identifying that the se-
quences grouped according to species and pathotypes (10).
SadA orthologues from intestinal E. coli isolates were more
conserved than proteins from extraintestinal, uropathogenic,
and environmental E. coli strains (Fig. 1B).
One of the positional orthologues identified was the E. coli
CFT073 UpaG (75). However, UpaG and SadA differ substan-
tially in protein sequence. UpaG is 317 aa longer than SadA,
due to extra amino acids in the N-terminal head, stalk, and
neck domains of the protein. The head domain in particular
differed in sequence from the analogous region in UpaG. Al-
though the full-length protein sequences shared 56.8% simi-
larity, the head domain shared only 30.4% similarity. In addi-
tion to this, the UpaG head sequence is over twice the length
of the SadA head region (Fig. 1A).
SadA is surface expressed in S. enterica SL1344. SadA was
overexpressed in E. coli BL21 pDR01, purified, and refolded as
described in Materials and Methods (Fig. 2A). The fluores-
cence spectrum of the refolded protein was typical of proteins
containing multiple tryptophans, with a broad band at half
height. The max was found at 336 nm, which indicates that the
tryptophans are in a folded conformation (Fig. 2B). The re-
folded material was analyzed by mass spectrometry identifica-
tion analysis and was identified as SadA, and analysis by silver
staining confirmed that the sample was
99% pure and had no
detectable LPS. An endotoxin detection assay also verified that
the sample had no detectable LPS (	0.05 endotoxin units
[EU] in 40 g protein). This purified protein was used for
infection studies (see below) and to raise polyclonal antibodies
to SadA.
As SadA belongs to the TAA family, it was expected to
adopt a 426-kDa homotrimeric conformation associated with
the outer membrane, with the passenger domain displayed on
the cell surface. The protein expressed in E. coli, and the
purified refolded form, are ca. 400 kDa, indicating that SadA
adopts a native form when expressed in E. coli. To confirm that
SadA was expressed and surface localized in S. enterica
SL1344, a number of assays were undertaken. First, RT-PCRs
were used to detect sadA expression in S. enterica SL1344
grown at 37°C in LB; notably, no transcript was detected for
the isogenic sadA null mutant (Fig. 2C). Next, the presence of
SadA in the outer membrane was confirmed using the anti-
FIG. 2. Purification, expression, and localization of SadA. (A) Stained SDS-PAGE gel of total cell protein extracts from E. coli BL21(pET22b)
(i) and E. coli BL21(pDR01) (SadA) (ii) and the protein sample after electroelution and purification (iii). L, PageRuler Plus protein ladder.
(B) Tryptophan fluorescence emission of refolded SadA. An excitation wavelength of 280 nm was used, and emission was scanned from 300 to 450
nm with 1-nm increments. (C) RT-PCR gel using sadA specific primers of wild-type S. enterica SL1344 (i) and isogenic sadA mutant (ii) grown in
LB at 37°C. L, HyperLadder I (Bioline). (D) Western immunoblot analysis using SadA-specific antibody from outer membrane preparations of
wild-type S. enterica SL1344 (i), mutant S. enterica SL1344 sadA (ii), and complemented S. enterica sadA(pDR03) (iii). (E) Localization of SadA
on the cell surface. S. enterica SL1344, S. enterica SL1344 sadA, and S. enterica sadA(pDR03) were probed with anti-SadA antibody followed
by GAR Alexa Fluor 488. Phase-contrast and fluorescence micrographs demonstrate labeling of the wild-type and complemented strains but not
the mutant strain. Two control experiments were performed in which SL1344 was treated with secondary antibody only or a different primary
antibody followed by the secondary antibody to rule out binding to immunoglobulins. Neither control had any labeling (not shown). Scale
bar, 0.5 m.
4346 RAGHUNATHAN ET AL. INFECT. IMMUN.
 o
n
 O
ctober 26, 2016 by University of Queensland Library
http://iai.asm
.org/
D
ow
nloaded from
 
SadA specific antibody; thus, a band of ca. 400 kDa was de-
tected in outer membrane preparations of wild-type S. enterica
SL1344 but not in an isogenic sadA mutant grown in LB at
37°C. Outer membrane localization of SadA was restored by
introducing plasmid pDR03 into S. enterica SL1344 sadA
(Fig. 2D); in addition to the trimeric form, a lower band,
consistent with monomeric SadA, was also detected when
SadA was overexpressed. Finally, the surface localization of
SadA was confirmed by immunofluorescence microscopy (Fig.
2E). S. enterica SL1344 displayed abundant surface labeling,
whereas the S. enterica SL1344 sadA mutant strain was devoid
of any labeling. The labeling was restored in the complemented
mutant S. enterica SL1344 sadA(pDR03). Interestingly, the
labeling is punctate in both the wild type and the comple-
mented mutant and in E. coli pDR01 strains (data not shown),
suggesting that localization is a phenomenon of spatial expres-
sion and not a product of variations in O-antigen length. Punc-
tate labeling has been observed previously for the prototypical
TAA, YadA (31), though other TAAs seem to have a variety of
surface expression patterns, including polar (75) and whole-
cell labeling (31). As some TAAs are known to bind immuno-
globulins (23), two further control experiments were per-
formed. First, the wild-type strain was incubated with the
fluorescently labeled secondary antibody only, and second, the
wild-type strain was incubated with a different primary anti-
body (anti-Pet) prior to the addition of fluorescently labeled
secondary antibody. In both controls, no labeling was detected
(data not shown).
Expression of SadA promotes biofilm formation and au-
toaggregation. Many of the TAAs characterized previously
promote biofilm formation and autoaggregation (23, 75).
To determine whether SadA also shared these phenotypic
properties, wild-type S. enterica SL1344, the sadA mutant
strain, and the complemented mutant strain [S. enterica
SL1344 sadA(pDR03)] were tested for their ability to pro-
mote biofilm formation and aggregation. No statistically sig-
nificant difference was seen in aggregation between the S.
enterica SL1344 wild type, the sadA mutant, and the com-
plemented strain (Fig. 3A). Similarly, in the polystyrene
biofilm assay, no difference in biofilm formation was seen
between S. enterica SL1344, the sadA isogenic mutant, and
the complemented strain S. enterica SL1344 sadA(pDR03)
overexpressing SadA (Fig. 3B).
Previous investigations have demonstrated that the function
of type V secreted molecules can be obscured in in vitro assays
by occlusion of the functional portion of the protein by other
surface structures, such as capsular polysaccharide or smooth
lipopolysaccharide (LPS) (33, 63, 67, 68, 74). To determine if
this was the case for SadA, we took two different approaches.
First, SadA was expressed in E. coli M15 lacking smooth LPS,
and second, we introduced a galE null mutation into S. enterica
SL3261 and its sadA mutant derivatives, resulting in strains
defective in O-antigen production. In contrast to wild-type
S. enterica SL1344, E. coli M15(pDR03) demonstrated sig-
nificant levels of autoaggregation (OD600  0.3/h), whereas
the strain carrying the empty vector (pQE60NdeI) did not
settle (OD600  0.1/h) (Fig. 3A). Similarly, the S. enterica
SL3261 sadA galE double mutant strain did not aggregate
(OD600  0.1/h), but the mutant expressing SadA did aggre-
gate (OD600  0.45/h) (Fig. 3C). These data clearly demon-
strate the capacity of SadA to induce autoaggregation.
To determine whether the LPS could be blocking the capac-
ity of SadA to mediate biofilm formation, E. coli M15 was
tested in the polystyrene biofilm assay. Compared to that of the
empty vector control, biofilm formation was significantly in-
creased when SadA was expressed from E. coli M15(pDR03)
(P 	 0.001) (Fig. 3B). Furthermore, under continuous-flow
conditions, SadA mediated a strong biofilm-forming pheno-
type in S. enterica lacking long O-antigen side chains; this
phenotype was absent from an isogenic mutant lacking SadA
expression (Fig. 3D). This verifies that SadA can induce bio-
film formation phenotypes in S. enterica.
SadA increases E. coli K-12 adherence to and invasion of
intestinal epithelial cells. All characterized TAAs have been
found to have a role in adhesion. To determine if the SadA
protein is also involved in adhesion, the strains described
above were tested for their abilities to adhere to or invade two
epithelial cell lines: the human intestinal Caco-2 cells and
murine J774 macrophages. No difference was detected be-
tween the abilities of S. enterica SL1344 and S. enterica SL1344
sadA::aph to adhere to or invade Caco-2 cells. However, when
SadA was expressed in E. coli M15, the ability of these bacteria
to adhere to (P 	 0.05) and invade (P 	 0.01) Caco-2 cells was
significantly increased (Fig. 4). In fact, E. coli M15(pDR03)
was five times more adherent and over 100 times more invasive
than the empty vector control E. coli M15(pQE60). No differ-
ence in adhesion to or invasion of J774 macrophages was
observed for any of the strains tested (data not shown). This
suggests that SadA can promote bacterial adherence to intes-
tinal cells but that in Salmonella, other factors can compensate
for the loss of sadA.
Many TAAs promote binding to extracellular matrix (ECM)
molecules (50, 62, 73), including the SadA homologue UpaG,
which binds to fibronectin and laminin (75). To determine if
expression of SadA also conferred this phenotype, the S. en-
terica SL1344 wild type and the sadA mutant, as well as E. coli
overexpressing SadA, were tested for their ability to adhere to
ECM molecules as previously performed (70). Our studies
were unable to detect any SadA-mediated adhesion to ECM
molecules collagen I, collagen III, collagen IV, elastin, fi-
bronectin, and laminin (data not shown).
Finally, ingestion of salad leaves contaminated with S. en-
terica strains has been associated with outbreaks of disease.
Specific adherence of S. enterica has been demonstrated (6, 7,
66). Thus, we investigated the ability of SadA to mediate bind-
ing of S. enterica SL1344, the sadA isogenic mutant, and
E. coli strains expressing SadA to rocket leaves. While strains
were capable of binding to the leaves, there was no significant
difference between those strains expressing SadA and those
which did not produce SadA (see Fig. S1 in the supplemental
material).
SadA does not promote serum resistance. YadA, the proto-
typical TAA, and other members of the type V secretion family
have been shown to confer the ability to resist complement-
mediated killing in serum (23, 35). Such serum resistance is an
important phenotype of invasive salmonellae, as it enables the
bacteria to survive in the blood (53). S. enterica SL1344, the
isogenic sadA mutant strain, and the complemented version
[S. enterica sadA(pDR03)] were tested for survival in human
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serum derived from healthy individuals. No difference in serum
resistance between the Salmonella strains was observed, all
being equally resistant. SadA was also unable to confer serum
resistance to E. coli, with both E. coli M15(pQE60) and
M15(pDR03) strains remaining serum sensitive (see Fig. S2 in
the supplemental material).
Evaluation of the role of SadA in the virulence of Salmonella
Typhimurium. As SadA had been shown to be involved in
adhesion, aggregation, and biofilm formation, we wanted to
test its role in virulence. A common model organism used to
study Salmonella infection is C. elegans, a hermaphroditic
worm, which has been used to identify Salmonella virulence
factors in the past (1). C. elegans N2 wild-type worms were
infected with either S. enterica SL1344 or S. enterica SL1344
sadA::aph, and the relative survival rates were compared. No
significant difference in survival rate was observed (see Fig. S3
in the supplemental material).
Since the worm model showed no attenuation of virulence,
we assessed the virulence of a sadA mutant in two murine
models of infection. First, the S. enterica sadA::aph mutation
was transferred to the S. enterica SL3261 strain using P22
transduction. This allowed any potential role for virulence to be
assessed over a longer period when CD4 T cells are required for
the resolution of infection. Wild-type C57BL/6 mice were in-
fected i.p. with S. enterica SL3261 or the isogenic sadA::aph mu-
tant. The mutant strain exhibited no attenuation compared to the
parental S. enterica SL3261 in the liver or spleen at all time points
(see Fig. S3 in the supplemental material).
As SadA mediates binding and invasion of intestinal epithe-
lial cells, but had no apparent role in disease when adminis-
tered by the i.p. route, we hypothesized that SadA may play a
role in the establishment of S. Typhimurium infection in the
intestine. To test this, mice were orally challenged with S.
enterica SL1344 or the isogenic sadA::aph mutant. No signifi-
FIG. 3. Autoaggregation and biofilm formation mediated by SadA. (A) Settling profiles of S. enterica SL1344, S. enterica SL1344 sadA, S.
enterica SL1344 sadA(pDR03), E. coli M15(pQE60), and E. coli M15(pDR03). Images show settling from static liquid suspensions in the
SadA-expressing E. coli M15 strain. (B) Biofilm formation of the five strains described for panel A in polystyrene plates. All strains were cultured
under conditions suitable for inducing sadA expression from pDR03. The data are the average of experiments with 8 replicate samples, performed
on three separate occasions. (C) Settling profiles of an S. enterica galE sadA double mutant and the double mutant expressing SadA (pDR03).
(D) Flow cell biofilms demonstrating the spatial distribution of the double mutant S. enterica SL3261 sadA galE::aph with either pQE60 or pDR03
after 18 h of growth. Shown are representative horizontal sections within each biofilm and vertical sections representing the yz plane and xz plane
at the positions indicated by the white dotted lines.
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cant difference was observed between the numbers of wild-type
and mutant bacteria present in either the spleen or liver at 4 of
6 days postinfection (see Fig. S3 in the supplemental material).
These data suggest that SadA is not required for the develop-
ment or maintenance of either oral or systemic Salmonella
infection in mice.
Immunization with alum-precipitated SadA induces marked
IgG titers and provides limited protection against S. Typhi-
murium infection. As SadA is surface expressed on the bacte-
rium, we tested whether immunization with purified SadA pro-
tein could reduce bacterial colonization after infection. Mice
were immunized according to the schedule shown in Fig. 5A,
being immunized twice (day 0 and day 30) with PBS, purified
SadA, or alum-precipitated SadA (SadA-Alum) before i.p.
challenge with S. enterica SL1344 14 days after the second
immunization. Mice were sacrificed 2 days postchallenge, and
the bacterial numbers in spleens and livers were recorded. In
addition, serum samples were taken before and after the chal-
lenge with the bacteria. Mice immunized with purified SadA-
Alum had 6.5-fold lower numbers of bacteria in the spleen
(P 	 0.05) and 10-fold fewer bacteria in the liver (P 	 0.01)
than the PBS control. Mice immunized with purified unadju-
vanted SadA had 10-fold fewer bacterial numbers in the liver
(P 	 0.01) than the control mice but no significant differences
in splenic bacterial numbers (Fig. 5B).
Assessment of antibody titers in mice prior to infection
showed that SadA-immunized mice induced marked IgG titers
against SadA and that the group that had the highest IgG titers
had the lowest bacterial burdens. While alum-precipitating
SadA augmented the IgG response, it was surprising to see a
potent anti-SadA IgG response in mice that had received the
protein without adjuvant (Fig. 5C). Finally, IgM titers to SadA
were examined in serum taken pre- and postchallenge from the
PBS control mice. As expected, no IgM response was seen in
FIG. 4. Adherence and invasion of S. enterica SL1344, S. enterica
SL1344 sadA::aph, E. coli M15(pQE60), and E. coli M15(pDR03)
(SadA) to intestinal Caco-2. The E. coli strain expressing SadA had
increased adhesion (P 	 0.05) and invasion (P 	 0.01) over the E. coli
strain with the empty plasmid.
FIG. 5. SadA induces an antibody response in mice. (A) Experimental design of challenge experiment. (B) Numbers of CFU recovered from
the livers and spleens of mice 2 days after challenge. Mice dosed with SadA-Alum had lower levels of S. enterica in both the spleen and liver than
the control, whereas mice dosed with SadA only had lower bacterial numbers in the liver. (C) Sera taken from mice prior to challenge with S.
enterica SL1344 were tested for relative amounts of SadA-specific IgG. SadA-specific IgG was found in mice dosed with SadA and SadA-Alum.
(D) SadA-specific IgM was found in serum from PBS control mice collected postchallenge but not in serum collected prechallenge, indicating SadA
expression in vivo during S. enterica SL1344 infection. (E) Numbers of CFU recovered from the spleens of mice infected with opsonized S. enterica
SL1344. Bacteria opsonized with the serum from SadA-immunized mice had a reduction in bacterial numbers compared to bacteria opsonized with
the PBS control serum.
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mice prechallenge; however, two of the three control mice had
a SadA-specific IgM response 2 days postchallenge with S.
enterica SL1344, indicating that SadA was being expressed in
vivo during infection (Fig. 5D).
To prove the protective effect of anti-SadA antibody, and to
rule out the influence of nonspecific effects or the effects of
innate immunity, bacteria were opsonized before mice were
infected. After 5 days, mice which were challenged with op-
sonized bacteria demonstrated a marginal but significant re-
duction in bacterial numbers compared to mice challenged
with nonopsonized bacteria (Fig. 5E). The reduction in bacte-
rial numbers was similar to that observed for mice immunized
with SadA. Taken together, the data indicate that SadA is
expressed in vivo during infection and can elicit a rapid immu-
nological response to itself but that preexisting IgG antibody to
SadA provokes only a modest protective effect against chal-
lenge in this host.
DISCUSSION
Proteins that use the type V secretion system represent an
increasingly important family of secreted virulence factors in
Gram-negative bacteria, not only for their contribution to vir-
ulence but also as targets for vaccine development (8, 79). Two
type V, or autotransporter (AT), proteins have previously been
characterized in S. Typhimurium: MisL and ShdA. These AT
proteins have a role in S. Typhimurium intestinal colonization
and persistence via binding to various ECM molecules (20,
41–43). In this study, we characterize SadA, the first trimeric
autotransporter adhesin (TAA) to be characterized in detail in
S. enterica. We demonstrate that SadA possesses functional
properties associated with biofilm formation, aggregation, and
adhesion to intestinal epithelial cells. Loss of SadA from the
bacterium does not affect the course of infection, and while
antibody to SadA can reduce bacterial colonization, this effect
is modest.
Although SadA is a clear positional orthologue of the pre-
viously characterized TAA UpaG from E. coli CFT073, this
study has revealed that they have differing functions. SadA is
similar to UpaG in that it promotes biofilm formation and
bacterial cell-cell aggregation, but nonetheless, it differs from
UpaG in adhesion phenotypes. In contrast to the findings for
UpaG, we were unable to detect SadA-mediated binding to
any ECM molecules (75). Despite the lack of ECM binding,
SadA does promote significant adhesion and invasion of
Caco-2 epithelial cells, whereas UpaG was reported to increase
binding to T24 epithelial cell lines, albeit very slightly (75).
These differences are most likely due to sequence differences
in the passenger domain. The passenger domains of UpaG and
SadA varied significantly (46.2% identity) in contrast to the
translocator (79.7% identity) and signal sequences (72.5%
identity). Further analysis of the passenger domain revealed
that the motifs in the predicted head region were more variable
than motifs in the stalk and neck structures. The head is re-
sponsible for the adhesion phenotype in other TAAs (50), and
thus, it is not surprising that SadA and UpaG have differing
adhesion phenotypes.
In contrast to the high sequence variability between SadA
and positional orthologues in E. coli strains, the orthologues of
SadA in S. enterica strains are highly conserved (over 97%
amino acid similarity). This is even more pronounced in the
SadA orthologues from the four sequenced S. Typhimurium
strains which share 100% amino acid identity. Similarly, the
majority of SadA orthologues in E. coli strains from intestinal
isolates are also highly conserved. The fact that the protein is
also in the same genomic location in all strains (including in
C. youngae) suggests that the gene has been maintained since
before Salmonella and E. coli diverged. These facts suggest
that SadA has an important function for the bacterium. The
conserved nature of the protein also infers that either SadA is
not under immunological pressure despite surface localization
or that the amino acid sequence must remain highly conserved
to maintain the functionality of the protein.
SadA was expressed in S. enterica SL1344 at low levels in
vitro. Interestingly, SadA is likely to be surface exposed in vivo
since IgM antibody to it was detectable within 2 days of infec-
tion. Our ongoing experiments indicate that SadA expression
may be increased at 42°C, the avian body temperature (data
not shown). As Salmonella is also highly associated with birds
(25), it may be that SadA plays a more significant role in avian
colonization.
SadA-mediated bacterial cell aggregation and biofilm for-
mation. These phenotypes have been implicated in persistence
and pathogenicity for many bacterial pathogens (5, 57, 64) and
are also associated with many AT and TAA proteins (78),
although no structural domains for these conserved functions
have yet been defined. Many other AT and TAA proteins that
do mediate aggregation and biofilm formation have other
more specific virulence functions, such as adhesion to epithe-
lial cells (75, 77) or extracellular matrix molecules (76), serum
resistance (23), and toxin and esterase activity. Likewise, SadA
has a further, more specific function, promoting adhesion to
and invasion of human intestinal epithelial cells (Caco-2) when
expressed in an E. coli background. Initial attachment and
invasion of human intestinal epithelial cells are vital for the
initiation of infection (55). As SadA can mediate adhesion and
invasion of Caco-2 cells when expressed in E. coli K-12, it may
play a role in the initial attachment and colonization of Sal-
monella in the host. Previous studies with TAA proteins that
bind epithelial cells have suggested that this is due to the ability
of the proteins to bind ECM components (75). As we could not
detect any SadA-mediated binding to ECM molecules, it is
likely that SadA has other binding targets on the epithelial cell
surface or binds to ECM molecules not tested in this study.
Although SadA is expressed in S. Typhimurium in vitro, no
difference in cell aggregation, biofilm formation, or adhesion
to Caco-2 epithelial cells was detected between the wild type
and sadA mutant strain. Large bacterial surface structures,
such as capsule, LPS, or fimbriae, have been shown to block
the function of AT proteins such as antigen 43 and EhaA (33,
63, 77). We demonstrated that by removing the O antigen from
S. Typhimurium, we could restore the aggregation and biofilm
formation phenotypes of SadA. This suggests that large surface
structures can block the function of SadA and expression of
surface factors needs to be carefully orchestrated in the bac-
terium for TAAs such as SadA to play a role in colonization
and infection. Thus, SadA may also be important under par-
ticular conditions where LPS production is reduced, such as
during macrophage infection (24).
No difference in virulence between the S. Typhimurium
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wild-type and sadA mutant strains was seen in any of the assays
performed. This may be due to functional redundancy with
other expressed outer membrane proteins which compensate
for the deletion of sadA. This is also seen for other AT proteins
characterized in S. Typhimurium. Although shown to be crit-
ical for maintenance of fecal shedding, there is no effect on
virulence when MisL and ShdA are deleted (20, 43). Indeed,
the roles of MisL, ShdA, and SadA may be compensatory; loss
of one AT may not reduce virulence, but loss of all three may
severely attenuate S. enterica. Studies to test such functional
redundancy are under way in our laboratory.
A surprising finding from this study was that SadA alone was
sufficient to drive a switched IgG response to itself in the
absence of exogenous adjuvant. This coupled to the finding
that during infection in naive mice, anti-SadA IgM was detect-
able within 48 h, suggests that this trimeric autotransporter is
likely to be recognized by selective B cell subsets, such as B1b
cells that are known to recognize Salmonella proteins such as
OmpD (26). Nevertheless, IgG antibody to SadA afforded lim-
ited protection of only a 10-fold reduction even when given
twice as an alum-precipitated protein. Recent studies have
shown that antibodies targeting the LPS of S. Typhimurium
inhibit complement-mediated killing in immunocompromised
individuals (52) despite being an immunodominant target of
the immune response. Therefore, collectively, the data from
this study and the described studies indicate that identifying
the most effective targets of antibody-mediated protection is
likely to be a complex process and may involve targeting mul-
tiple antigens in parallel.
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